| pubmed-article:9125254 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9125254 | lifeskim:mentions | umls-concept:C0003873 | lld:lifeskim |
| pubmed-article:9125254 | lifeskim:mentions | umls-concept:C0012634 | lld:lifeskim |
| pubmed-article:9125254 | lifeskim:mentions | umls-concept:C0022658 | lld:lifeskim |
| pubmed-article:9125254 | lifeskim:mentions | umls-concept:C0005516 | lld:lifeskim |
| pubmed-article:9125254 | lifeskim:mentions | umls-concept:C0103647 | lld:lifeskim |
| pubmed-article:9125254 | lifeskim:mentions | umls-concept:C0205082 | lld:lifeskim |
| pubmed-article:9125254 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:9125254 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:9125254 | pubmed:dateCreated | 1997-4-24 | lld:pubmed |
| pubmed-article:9125254 | pubmed:abstractText | To evaluate the clinical significance of antineutrophil cytoplasmic antibodies (ANCA) in patients with rheumatoid arthritis (RA), and especially in those with clinically suspected or histologically proven nephropathy. | lld:pubmed |
| pubmed-article:9125254 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9125254 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9125254 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9125254 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9125254 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9125254 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9125254 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9125254 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:9125254 | pubmed:issn | 0004-3591 | lld:pubmed |
| pubmed-article:9125254 | pubmed:author | pubmed-author:MiettinenAA | lld:pubmed |
| pubmed-article:9125254 | pubmed:author | pubmed-author:PasternackAA | lld:pubmed |
| pubmed-article:9125254 | pubmed:author | pubmed-author:SoppiEE | lld:pubmed |
| pubmed-article:9125254 | pubmed:author | pubmed-author:HelinHH | lld:pubmed |
| pubmed-article:9125254 | pubmed:author | pubmed-author:MustonenJJ | lld:pubmed |
| pubmed-article:9125254 | pubmed:author | pubmed-author:HuhtalaHH | lld:pubmed |
| pubmed-article:9125254 | pubmed:author | pubmed-author:KorpelaMM | lld:pubmed |
| pubmed-article:9125254 | pubmed:author | pubmed-author:MustilaAA | lld:pubmed |
| pubmed-article:9125254 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9125254 | pubmed:volume | 40 | lld:pubmed |
| pubmed-article:9125254 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9125254 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9125254 | pubmed:pagination | 710-7 | lld:pubmed |
| pubmed-article:9125254 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9125254 | pubmed:meshHeading | pubmed-meshheading:9125254-... | lld:pubmed |
| pubmed-article:9125254 | pubmed:meshHeading | pubmed-meshheading:9125254-... | lld:pubmed |
| pubmed-article:9125254 | pubmed:meshHeading | pubmed-meshheading:9125254-... | lld:pubmed |
| pubmed-article:9125254 | pubmed:meshHeading | pubmed-meshheading:9125254-... | lld:pubmed |
| pubmed-article:9125254 | pubmed:meshHeading | pubmed-meshheading:9125254-... | lld:pubmed |
| pubmed-article:9125254 | pubmed:meshHeading | pubmed-meshheading:9125254-... | lld:pubmed |
| pubmed-article:9125254 | pubmed:meshHeading | pubmed-meshheading:9125254-... | lld:pubmed |
| pubmed-article:9125254 | pubmed:meshHeading | pubmed-meshheading:9125254-... | lld:pubmed |
| pubmed-article:9125254 | pubmed:meshHeading | pubmed-meshheading:9125254-... | lld:pubmed |
| pubmed-article:9125254 | pubmed:meshHeading | pubmed-meshheading:9125254-... | lld:pubmed |
| pubmed-article:9125254 | pubmed:meshHeading | pubmed-meshheading:9125254-... | lld:pubmed |
| pubmed-article:9125254 | pubmed:meshHeading | pubmed-meshheading:9125254-... | lld:pubmed |
| pubmed-article:9125254 | pubmed:meshHeading | pubmed-meshheading:9125254-... | lld:pubmed |
| pubmed-article:9125254 | pubmed:meshHeading | pubmed-meshheading:9125254-... | lld:pubmed |
| pubmed-article:9125254 | pubmed:meshHeading | pubmed-meshheading:9125254-... | lld:pubmed |
| pubmed-article:9125254 | pubmed:meshHeading | pubmed-meshheading:9125254-... | lld:pubmed |
| pubmed-article:9125254 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9125254 | pubmed:articleTitle | Perinuclear antineutrophil cytoplasmic antibody in rheumatoid arthritis: a marker of severe disease with associated nephropathy. | lld:pubmed |
| pubmed-article:9125254 | pubmed:affiliation | Department of Clinical Microbiology, Tampere University Hospital, Finland. | lld:pubmed |
| pubmed-article:9125254 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9125254 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9125254 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9125254 | lld:pubmed |
